Skip to main content

Intervention of a Health Education Clinical Nursing Pathway Among Patients with Ovarian Carcinoma

2021 Year in Review - Ovarian Cancer - Ovarian Cancer

Results from a retrospective analysis indicate that health education, using a clinical nursing pathway, results in a more effective understanding of ovarian cancer, reduced psychological burden, improved sleep quality, decreased incidence of complications, improved self-care agency, and improved quality of life among patients with ovarian cancer.

A retrospective study investigated the effect of health education on several parameters, including self-care agency, quality of life, negative emotions, and nursing satisfaction among patients with ovarian carcinoma. Results of this analysis were published in the American Journal of Translational Research.

The study identified patients with stage I or II ovarian carcinoma, aged between 30 and 60 years, treated at a hospital in China from January 2019 to January 2020; the clinical data for these patients were analyzed. Patients were classified into 2 groups: a control group that received health education per routine nursing, and an observation group that received the intervention via a specified clinical nursing pathway. Several parameters were analyzed between the 2 groups before and after the intervention, including postoperative complications such as deep vein thrombosis; self-care agency score; quality-of-life score, as evaluated by the Quality-of-Life Questionnaire-30; and health knowledge, as assessed by an ovarian carcinoma knowledge questionnaire. Sleep quality, as evaluated by the Pittsburgh Sleep Quality Index; negative emotions, as assessed by the Hamilton Anxiety Scale and Hamilton Depression Scale; and nursing satisfaction were also assessed.

A total of 61 patients were included in the study; 31 patients were included in the control group and 30 patients in the observation group. Following the health education intervention, patients in the observation group showed significantly higher levels of health knowledge and lower incidence of postoperative complications than those in the control group. The scores of negative emotions and sleep quality were significantly decreased in both groups after intervention compared with those before intervention (P <.05), and scores in the observation group were significantly lower than those in the control group (P <.05). Similarly, scores of self-care agency and quality of life were significantly higher after intervention than before intervention (P <.05); moreover, patients in the observation group showed higher scores than those in the control group (P <.05). Patients indicated that overall nursing satisfaction was relatively high.

Based on these results, the investigators concluded that health education intervention via a clinical nursing pathway can yield a more effective understanding of ovarian cancer, reduced psychological burden, improved sleep quality, decreased incidence of complications, improved self-care agency, and improved quality of life among patients with ovarian cancer.

Source: Zhao J, Chai G, Yang F, et al. Analysis of the change of clinical nursing pathway in health education among patients with ovarian carcinoma. Am J Transl Res. 2021;13:3138-3146.

Related Items
How to Sequence Treatment in Relapsed Ovarian Cancer
2021 Year in Review - Ovarian Cancer published on January 18, 2022 in Ovarian Cancer
Maintenance Gemogenovatucel-T Immunotherapy in Newly Diagnosed Advanced Ovarian Cancer
2021 Year in Review - Ovarian Cancer published on January 18, 2022 in Ovarian Cancer
Patient Self-Reporting of Tolerability in Phase 2 Trial Comparing Gemcitabine plus Adavosertib or Placebo in Women with Platinum-Resistant Epithelial Ovarian Cancer
2021 Year in Review - Ovarian Cancer published on January 18, 2022 in Ovarian Cancer
Mirvetuximab Soravtansine plus Bevacizumab in Patients with Recurrent Ovarian Cancer
2021 Year in Review - Ovarian Cancer published on January 18, 2022 in Ovarian Cancer
NeoPembrOV Study of Neoadjuvant Chemotherapy with or without Pembrolizumab Followed by Interval Debulking Surgery and Standard Systemic Therapy with or without Pembrolizumab for Advanced High-Grade Serous Carcinoma
2021 Year in Review - Ovarian Cancer published on January 18, 2022 in Ovarian Cancer
Optimal Treatment Duration of Bevacizumab plus Carboplatin/Paclitaxel in Advanced Ovarian Cancer
2021 Year in Review - Ovarian Cancer published on January 18, 2022 in Ovarian Cancer
Phase 1 Study of GAS6/AXL Inhibitor (AVB-500) in Recurrent, Platinum-Resistant Ovarian Carcinoma
2021 Year in Review - Ovarian Cancer published on January 18, 2022 in Ovarian Cancer
Anlotinib in Combination with TQB2450 in Patients with Recurrent Ovarian Cancer (ACTION)
2021 Year in Review - Ovarian Cancer published on January 18, 2022 in Ovarian Cancer
Niraparib Efficacy and Safety in Patients with BRCA-Mutated Ovarian Cancer from 3 Phase 3 Trials
2021 Year in Review - Ovarian Cancer published on January 18, 2022 in Ovarian Cancer
Real-World Treatment Patterns of Maintenance Therapy in Platinum-Sensitive Recurrent Ovarian Cancer
2021 Year in Review - Ovarian Cancer published on January 18, 2022 in Ovarian Cancer